Dysregulation of OSBP has been demonstrated to influence the survival of breast cancer patients [107], and OSBP-related proteins such as ORP2 have been recorded to increase EMT activities in cancers like pancreatic cancer to accelerate cancer progression [108]. This evidence concerns the gene OSBP and breast carcinoma.